Potential Diagnostic Value Of Combining Inflammatory Cell Ratios With Carcinoembryonic Antigen For Colorectal Cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–1502. doi:10.1016/S0140-6736(13)61649-924225001
   PubMed Web of Science ®Google Scholar
• Lieberman D. Colorectal cancer screening with colonoscopy. JAMA Intern Med. 2016;176(7):903–904. doi:10.1001/jamainternmed.2016.133327214200
   PubMed Web of Science ®Google Scholar
• McKeown E, Nelson DW, Johnson EK, et al. Current approaches and challenges for monitoring treatment response in colon and rectal cancer. J Cancer. 2014;5(1):31–43. doi:10.7150/jca.798724396496
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867. doi:10.1038/nature0132212490959
   PubMed Web of Science ®Google Scholar
• Kuraishy A, Karin M, Grivennikov SI. Tumor promotion via injury- and death-induced inflammation. Immunity. 2011;35(4):467–477. doi:10.1016/j.immuni.2011.09.00622035839
   PubMed Web of Science ®Google Scholar
• Cho Y, Lee J, Oh J, et al. Inflammatory dietary pattern, IL-17F genetic variant, and the risk of colorectal cancer. Nutrients. 2018;10(6):724. doi:10.3390/nu10060724
   PubMed Web of Science ®Google Scholar
• Garcia-Anguita A, Kakourou A, Tsilidis KK. Biomarkers of inflammation and immune function and risk of colorectal cancer. Curr Colorectal Cancer Rep. 2015;11(5):250–258. doi:10.1007/s11888-015-0282-526321888
   PubMedGoogle Scholar
• Jia J, Zheng X, Chen Y, et al. Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer. Tumor Biol. 2015;36(12):9319–9325. doi:10.1007/s13277-015-3667-9
   PubMedGoogle Scholar
• Tan D, Fu Y, Tong W, Li F. Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: a meta-analysis. Int J Surg. 2018;55:128–138. doi:10.1016/j.ijsu.2018.05.03029807167
   PubMed Web of Science ®Google Scholar
• Holm M, Saraswat M, Joenväärä S, Ristimäki A, Haglund C, Renkonen R. Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics. PLoS One. 2018;13(4):e0195354. doi:10.1371/journal.pone.019535429630649
   PubMed Web of Science ®Google Scholar
• Sun L, Hu S, Yu L, et al. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis. Int J Cancer. 2016;138(11):2724–2731. doi:10.1002/ijc.v138.1126756179
   PubMed Web of Science ®Google Scholar
• González-Trejo S, Carrillo JF, Carmona-Herrera DD, et al. Baseline serum albumin and other common clinical markers are prognostic factors in colorectal carcinoma. Medicine. 2017;96(15):e6610. doi:10.1097/MD.000000000000661028403106
   PubMed Web of Science ®Google Scholar
• Kilincalp S, Çoban Ş, Akinci H, et al. Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomarkers for early detection and monitoring of colorectal adenocarcinoma. Eur J Cancer Prev. 2015;24(4):328–333. doi:10.1097/CEJ.000000000000009225304028
   PubMed Web of Science ®Google Scholar
• Kostakis ID, Vaiopoulos AG, Garoufalia Z, et al. What can preoperative blood tests tell us about colorectal cancer? J Buon. 2018;23(7):84–95.30722116
   PubMedGoogle Scholar
• Peng H-X, Yang L, He B-S, et al. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC. J Clin Lab Anal. 2017;31(5):e22075. doi:10.1002/jcla.2017.31.issue-5
   PubMed Web of Science ®Google Scholar
• Wu Y, Jiang M, Qin Y, Lin F, Lai M. Single and combined use of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and carcinoembryonic antigen in diagnosing gastric cancer. Clin Chim Acta. 2018;481:20–24. doi:10.1016/j.cca.2018.02.02729476736
   PubMed Web of Science ®Google Scholar
• Liu XF, Zhou LY, Wei ZH, et al. The diagnostic role of circulating inflammation-based biomarker in gallbladder carcinoma. Biomark Med. 2018;12(10):1095–1103. doi:10.2217/bmm-2018-004930191731
   PubMed Web of Science ®Google Scholar
• Weiser MR. AJCC 8th edition: colorectal cancer. Ann Surg Oncol. 2018;25(6):1454–1455. doi:10.1245/s10434-018-6462-129616422
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature0720518650914
   PubMed Web of Science ®Google Scholar
• Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology. 2011;140(6):1807–1816. doi:10.1053/j.gastro.2011.01.05721530747
   PubMed Web of Science ®Google Scholar
• Li MX, Liu XM, Zhang XF, et al. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2014;134(10):2403–2413. doi:10.1002/ijc.2853624122750
   PubMed Web of Science ®Google Scholar
• Min GT, Wang YH, Yao N, et al. The prognostic role of pretreatment platelet-to-lymphocyte ratio as predictors in patients with colorectal cancer: a meta-analysis. Biomark Med. 2017;11(1):87–97. doi:10.2217/bmm-2016-018127917650
   PubMed Web of Science ®Google Scholar
• Chan JCY, Chan DL, Diakos CI, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg. 2017;265(3):539–546. doi:10.1097/SLA.000000000000174327070934
   PubMed Web of Science ®Google Scholar
• Schlesinger M. Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol. 2018;11:1. doi:10.1186/s13045-018-0669-229298689
   PubMed Web of Science ®Google Scholar
• Plantureux L, Crescence L, Dignat-George F, Panicot-Dubois L, Dubois C. Effects of platelets on cancer progression. Thromb Res. 2018;164:S40–S47. doi:10.1016/j.thromres.2018.01.03529703484
   PubMed Web of Science ®Google Scholar
• Mezouar S, Mege D, Darbousset R, et al. Involvement of platelet-derived microparticles in tumor progression and thrombosis. Semin Oncol. 2014;41(3):346–358. doi:10.1053/j.seminoncol.2014.04.01025023350
   PubMed Web of Science ®Google Scholar
• Monreal M, Fernandez-Llamazares J, Pinol M, et al. Platelet count and survival in patients with colorectal cancer–a preliminary study. Thromb Haemost. 1998;79(5):916–918. doi:10.1055/s-0037-16150939609220
   PubMed Web of Science ®Google Scholar
• Ferradini L, Miescher S, Stoeck M, et al. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma. Int J Cancer. 1991;47(3):362–370. doi:10.1002/(ISSN)1097-02151899651
   PubMed Web of Science ®Google Scholar
• Matsuzaki J, Gnjatic S, Mhawech-Fauceglia P, et al. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc National Acad Sci. 2010;107(17):7875–7880. doi:10.1073/pnas.1003345107
   PubMed Web of Science ®Google Scholar
• Takahashi A, Kono K, Amemiya H, Iizuka H, Fujii H, Matsumoto Y. Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer. Clin Cancer Res. 2001;7(1):74–80.11205921
   PubMed Web of Science ®Google Scholar
• Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4(1):71–78. doi:10.1038/nrc125614708027
   PubMed Web of Science ®Google Scholar
• Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006;124(2):263–266. doi:10.1016/j.cell.2006.01.00716439202
   PubMed Web of Science ®Google Scholar
• Tanio A, Saito H, Uejima C, et al. A prognostic index for colorectal cancer based on preoperative absolute lymphocyte, monocyte, and neutrophil counts. Surg Today. 2019;49(3):245–253. doi:10.1007/s00595-018-1728-630382360
   PubMed Web of Science ®Google Scholar